Mast cells induce the inflammatory process when their FcΕRI receptors aggregate in response to an antigen binding to immunoglobulin E. Direct interactions between FcΕRI receptor cytoplasmic domains and various intracellular proteins initiate diverse signal transduction pathways resulting in the immediate release of proinflammatory agents. A delayed response also occurs that includes the release of various cytokines. It is clear that the activation of kinases, such as protein kinase C (PKC), is a requirement for both the early and delayed responses of this inflammatory process. In this review we present the results of various studies investigating the role of PKC isozymes in mast cells.

Keywords:
Protein kinase C isozymes, Mast cells, Gene expression, USF2, Cytokines
1.
Stevens RL, Austen KF: Recent advances in the cellular and molecular biology of mast cells. Immunol Today 1989;10:381–386.
2.
Beaven M, Metzger H: Signal transduction by Fc receptors: The FcεRI case. Immunol Today 1993;14:222–226.
3.
Benhamau M, Siraganian RP: Protein-tyrosine phosphorylation: An essential component of FCεRI signaling. Immunol Today 1992;13:195–197.
4.
Naor Z, Cohen-Dan H, Hermon J, Limor R: Induction of exocytosis in permeabilized pituitary cells by a- and b-type protein kinase C. Proc Natl Acad Sci USA 1989;86:4501–4504.
5.
Ozawa K, Szallasi Z, Kazanietz MG, Blumberg PM, Mischak H, Mushinski JF, Beaven M: Ca2+-dependent and Ca2+-independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated rat basophilic RBL-1H3 cells. Reconstitution of secretory responses with Ca2+ and purified isozymes in washed permeabilized cells. J Biol Chem 1993;268:1749–1756.
6.
Germano P, Gomez J, Kazanietz MG, Blumberg PM, Rivera J: Phosphorylation of the gamma chain of the high affinity receptor for immunoglobulin E by receptor-associated protein kinase C-d. J Biol Chem 1994;269:23102–23107.
7.
Song JS, Swann PG, Szallasi Z, Blank U, Blumberg PM, Rivera J: Tyrosine phosphorylation-dependent and -independent associations of protein kinase Cd with Src family kinases in the RBL-2H3 mast cell line: Regulation of Src family kinase activity by protein kinase Cd. Oncogene 1998;16:3357–3368.
8.
Leitges M, Schmedt C, Guinamard R, Davoust J, Schaal S, Stabel S, Tarakhovsky A: Immunodeficiency in protein kinase C beta deficient mice. Science 1996;273:788–791.
9.
Nechushtan H, Leitges M, Cohen C, Kay G, Razin E: Inhibition of degranulation and interleukin-6 production in mast cells derived from mice deficient in protein kinase Cβ. Blood 2000;95:1752–1757.
10.
Tamir A, Isakov N: Cyclic AMP inhibits phosphatidylinositol-coupled and -uncoupled mitogenic signals in T lymphocytes. Evidence that cAMP alters PKC-induced transcription regulation of members of the jun and fos family of genes. J Immunol 1994;152:3391–3399.
11.
Baranes D, Razin E: Protein kinase C regulates proliferation of mast cells and the expression of the mRNA of fos and jun proto-oncogenes during activation by IgE-Ag or calcium ionophore A23187. Blood 1991;78:2354–2364.
12.
Lewin I, Nechushtan H, Qingen K, Razin E: Regulation of AP-1 expression and activity in antigen-stimulated mast cells: The role played by protein kinase C and the possible involvement of Fos interacting protein. Blood 1993;82:3745–3751.
13.
Nechushtan H, Razin E: Deciphering the early-response transcription factor network in mast cells. Immunol Today 1998;19:441–444.
14.
Razin E, Szallasi Z, Kazanietz M, Blumberg PM, Rivera J: Protein kinase C-β and ε link the mast cell high affinity receptor for IgE to the expression of c-fos and c-jun. Proc Natl Acad Sci USA 1994;91:7722–7726.
15.
Frenkel S, Kay G, Nechushtan H, Razin E: Nuclear translocation of upstream stimulating factor 2 (USF2) in activated mast cells: A possible role in their survival. J Immunol 1998;161:2881–2887.
16.
Lewin I, Jacob-Hirsch J, Zang ZC, Kupershtein V, Szallasi Z, Rivera J, Razin E: Aggregation of the FcεRI in mast cells induces the synthesis of Fos-interacting protein and increases its DNA binding activity: The dependence on protein kinase C-β. J Biol Chem 1996;271:1514–1519.
17.
Zhang ZC, Nechushtan H, Jacob-Hirsch J, Avni D, Meyuhas O, Razin E: Growth-dependent and PKC-mediated translational regulation of the upstream stimulating factor-2 (USF2) mRNA in hematopoietic cells. Oncogene 1998;16:763–769.
18.
Shaikh N, Rivera J, Hewlett BR, Stead RH, Zhu FG, Marshall JS: Mast cell FcεRI expression in the rat intestinal mucosa and tongue is enhanced during Nippostrongylus brasiliensi s infection and can be up-regulated by in vivo administration of IgE. J Immunol 1997;158:3805–3812.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.